Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore P Nicolaides

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Cancer Therapeutics|July 5, 2019
Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBMAndrew McKinney, Olle R Lindberg, Jane R Engler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Cancer Therapeutics|July 5, 2019
Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBMAndrew McKinney, Olle R Lindberg, Jane R Engler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase-mutant GliomaMarissa Spino, Sylvia C Kurz, Luis Chiriboga, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Pageof 2